Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Behavioural Brain Research
|
February 7, 2021
The role of pro- and mature neurotrophins in the depression
Ying Xue, Hongyan Liang, Rui Yang, et al.
Clinical Transplantation
|
August 13, 2025
Population Pharmacokinetics and Limited Sampling Strategy of Mycophenolate Mofetil for Patients in Early Period After Kidney Transplantation
Kunhong Deng, Jinlong Liu, Yaxin Liu, et al.
Frontiers in Nutrition
|
April 4, 2022
Carnitine and Depression
Ting Liu, Kunhong Deng, Ying Xue, et al.
Cancer Medicine
|
July 16, 2022
Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single-center, open-label phase I trial
Kunhong Deng, Yi Zou, Chan Zou, et al.
Frontiers in Immunology
|
October 20, 2025
Comprehensive disproportionality analysis of individual case safety reports associated with Janus kinase inhibitors in psoriasis and psoriatic arthritis using the FAERS database
Kunhong Deng, Han Jiang, Shan Xie, et al.
Frontiers in Pharmacology
|
May 25, 2026
A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream (HZ-J001) in healthy Chinese subjects
Kunhong Deng, Jie Huang, Qian Wu, et al.
European Journal of Pharmacology
|
February 7, 2026
Safety, Pharmacokinetics, and Sex Hormone Suppression of LY01021 versus Relugolix: A Single- and Multiple-Dose Escalation Study
Yafen Li, Hongyi Tan, Jinlian Xie, et al.
Diabetes, Obesity & Metabolism
|
April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or Obesity
Jinlian Xie, Jie Huang, Qian Wu, et al.
Expert Opinion on Investigational Drugs
|
June 8, 2026
Safety, tolerability, and pharmacokinetics of HL-300, a novel topical Pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial
Hui Qiu, Xingfei Zhang, Jie Huang, et al.
Frontiers in Cardiovascular Medicine
|
June 1, 2022
Long Short-Term Memory Network for Development and Simulation of Warfarin Dosing Model Based on Time Series Anticoagulant Data
Yun Kuang, Yaxin Liu, Qi Pei, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Behavioural Brain Research
|
February 7, 2021
The role of pro- and mature neurotrophins in the depression
Ying Xue, Hongyan Liang, Rui Yang, et al.
Clinical Transplantation
|
August 13, 2025
Population Pharmacokinetics and Limited Sampling Strategy of Mycophenolate Mofetil for Patients in Early Period After Kidney Transplantation
Kunhong Deng, Jinlong Liu, Yaxin Liu, et al.
Frontiers in Nutrition
|
April 4, 2022
Carnitine and Depression
Ting Liu, Kunhong Deng, Ying Xue, et al.
Cancer Medicine
|
July 16, 2022
Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single-center, open-label phase I trial
Kunhong Deng, Yi Zou, Chan Zou, et al.
Frontiers in Immunology
|
October 20, 2025
Comprehensive disproportionality analysis of individual case safety reports associated with Janus kinase inhibitors in psoriasis and psoriatic arthritis using the FAERS database
Kunhong Deng, Han Jiang, Shan Xie, et al.
Frontiers in Pharmacology
|
May 25, 2026
A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream (HZ-J001) in healthy Chinese subjects
Kunhong Deng, Jie Huang, Qian Wu, et al.
European Journal of Pharmacology
|
February 7, 2026
Safety, Pharmacokinetics, and Sex Hormone Suppression of LY01021 versus Relugolix: A Single- and Multiple-Dose Escalation Study
Yafen Li, Hongyi Tan, Jinlian Xie, et al.
Diabetes, Obesity & Metabolism
|
April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or Obesity
Jinlian Xie, Jie Huang, Qian Wu, et al.
Expert Opinion on Investigational Drugs
|
June 8, 2026
Safety, tolerability, and pharmacokinetics of HL-300, a novel topical Pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial
Hui Qiu, Xingfei Zhang, Jie Huang, et al.
Frontiers in Cardiovascular Medicine
|
June 1, 2022
Long Short-Term Memory Network for Development and Simulation of Warfarin Dosing Model Based on Time Series Anticoagulant Data
Yun Kuang, Yaxin Liu, Qi Pei, et al.
Page
of 2